Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Myocarditis, kidney injury, and hypereosinophilia: FIP1L1-PDGFRA -positive myeloid/lymphoid neoplasm with eosinophilia

Sarah E. Reid, Shyam A. Patel

Blood (2021) 138 (12): 1086.

https://doi.org/10.1182/blood.2021011930

Published: 2021

Journal Articles

Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience

Rory M Shallis, MD, Jan Philipp Bewersdorf, MD, Lohith Gowda, MD, Nikolai A. Podoltsev, MD PhD, Thomas Prebet, MD PhD, Steven D. Gore, MD, Stephanie Halene, MD, Iris Isufi, MD, Francine M. Foss, MD, Scott F. Huntington, MD MPH, Tae Kon Kim, MD PhD, Manoj M Pillai, MD, Terri L Parker, MD, Natalia Neparidze, MD, Noffar Bar, MD, Stuart Seropian, MD, Amer M. Zeidan, MBBS, MHS

Blood (2019) 134 (Supplement_1): 1330.

https://doi.org/10.1182/blood-2019-127422

Published: 2019

Journal Articles

Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML

Blood (2019) 134 (Supplement_1): 831.

https://doi.org/10.1182/blood-2019-126065

Published: 2019

Journal Articles

Pattern of Immune-Mediated Toxicities in Patients with Myelodysplastic Syndrome (MDS) Treated with Nivolumab and Ipilimumab

Blood (2018) 132 (Supplement 1): 4367.

https://doi.org/10.1182/blood-2018-99-116714

Published: 2018

Journal Articles

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Rehan Ansari, MD, Elva Nora Osuna Salazar, MD, Nabeel Sarhill, MD, Laura E Garcia, MD, James Hanley, MD

Blood (2018) 132 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2018-99-118271

Published: 2018

Journal Articles

Frequency of Anti-PF4/Heparin Antibodies in Patients Treated with Extra-Corporeal Membrane Oxygenation and Detection By Sensitized Serotonin Release Assay of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Caroline Vayne, PharmD, Marc-Antoine May, MD, Thierry Bourguignon, MD PhD, Eric Lemoine, MD, Eve-Anne Guéry, PharmD, Jérôme Rollin, PhD, Yves Gruel, MD PhD, Claire Pouplard, PharmD, PhD

Blood (2018) 132 (Supplement 1): 1143.

https://doi.org/10.1182/blood-2018-99-114571

Published: 2018

Journal Articles

Splenectomy Is a Risk Factor for Cardiac Complications in TM

Antonella Meloni, PhD, Laura Pistoia, MD, Angela Ciancio, Vincenzo Santamaria, Francesco Sorrentino, MD, Carla Cirotto, Alessandra Quota, MD, Nicola Romano, Aurelio Maggio, MD, Riccardo Righi, Nicolò Schicchi, Alessia Pepe, MD

Blood (2017) 130 (Supplement 1): 2225.

https://doi.org/10.1182/blood.V130.Suppl_1.2225.2225

Published: 2017

Journal Articles

Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab and Bendamustine in Patients with Previously Untreated Follicular Lymphoma: An Interim Analysis

Anas Younes, MD, Burke M. John, Catherine S Diefenbach, Silvia Ferrari, Cyrus Kahn, Jeffrey P. Sharman, MD, Monica Tani, Chaitra S. Ujjani, MD, Umberto Vitolo, MD, Sam Yuen, Paul Woodard, Kirsten Mundt, Günter Fingerle-Rowson, Surya Chitra, Gila Sellam, Rodica Morariu-Zamfir, Michael Gilbertson

Blood (2017) 130 (Supplement 1): 481.

https://doi.org/10.1182/blood.V130.Suppl_1.481.481

Published: 2017

Journal Articles

Optimizing Checkpoint Blockade As a Treatment for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

Blood (2017) 130 (Supplement 1): 275.

https://doi.org/10.1182/blood.V130.Suppl_1.275.275

Published: 2017

Journal Articles

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

Bhavisha Patel, MD, Barac Ana, MD, Kelly W. Fitzpatrick, MD, Aarthi Shenoy, MD

Blood (2017) 130 (Supplement 1): 5032.

https://doi.org/10.1182/blood.V130.Suppl_1.5032.5032

Published: 2017

Journal Articles

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Carlo Marani, MD, Silvia Morbelli, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Giulia Ferrarazzo, MD, Sandro Nati, MD, Marina Congiu, MD, Stefania Bregante, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3489.

https://doi.org/10.1182/blood.V128.22.3489.3489

Published: 2016

Journal Articles

Carfilzomib in Combination with Bendamustine and Dexamethasone (CBd) in Relapsed and/or Refractory Patients with Multiple Myeloma: The Phase I/II EMN09 Study

Martin Gramatzki, Andreas Günther, Massimo Offidani, MD, Monika Engelhardt, Paolo Corradini, Silvia Gentili, Vittorio Montefusco, Francesca Patriarca, MD, Natalie Schub, Hermann Einsele, MD, Pieter Sonneveld, Antonio Palumbo, MD, Francesca Gay

Blood (2016) 128 (22): 3334.

https://doi.org/10.1182/blood.V128.22.3334.3334

Published: 2016

Journal Articles

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Shigesaburo Miyakoshi, MD PhD, Kensuke Usuki, MD PhD, Itaru Matsumura, MD PhD, Yasunori Ueda, MD PhD, Hiromi Iwasaki, MD PhD, Toshihiro Miyamoto, MD PhD, Makoto Origuchi, Shuzo Tagashira, Ichiro Naoi, Tomoki Naoe, MD PhD, Masahiro Kizaki, MD PhD, Yuji Heike, MD PhD, Koichi Akashi, MD PhD, Yasushi Miyazaki, MD PhD

Blood (2016) 128 (22): 4335.

https://doi.org/10.1182/blood.V128.22.4335.4335

Published: 2016

Journal Articles

Role of the Thrombin-PAR-1 Pathway in Coxsackievirus Induced Hepatitis

Kohei Tatsumi, MD,PhD, Silvio Antoniak, PhD, Nigel Mackman, PhD

Blood (2014) 124 (21): 1470.

https://doi.org/10.1182/blood.V124.21.1470.1470

Published: 2014

Journal Articles

Assessment of Incidence Toxoplasma Gondii Infection and Outcomes in Allogeneic Stem Cell Patients

Blood (2014) 124 (21): 1187.

https://doi.org/10.1182/blood.V124.21.1187.1187

Published: 2014

Journal Articles

Dysregulated Overexpression of S100A8 and S100A9 Calgranulin Family Proteins in IFNγR-/- Allogeneic T Cells Is Associated with Reduced Graft Versus Host Disease in Vivo

Matthew L Cooper, PhD, Jaebok Choi, PhD, Julie Ritchey, John F. DiPersio, MD PhD

Blood (2014) 124 (21): 3828.

https://doi.org/10.1182/blood.V124.21.3828.3828

Published: 2014

Journal Articles

Multiple roles of the coagulation protease cascade during virus infection

Silvio Antoniak, Nigel Mackman

Blood (2014) 123 (17): 2605–2613.

https://doi.org/10.1182/blood-2013-09-526277

Published: 2014

Journal Articles

A Randomized Comparison Of Maintenance Therapy With Subcutaneous Rituximab For 2 Years Versus Until Progression In Patients With Indolent Non-Hodgkin’s Lymphoma: Interim Safety Data From The Mabcute Study

Simon Rule, MD, Javier Briones, MD, Angelo Michele Carella, MD, Olivier Casasnovas, MD, Wolney Gois Barreto, MD, Christopher Pocock, PhD, Stuart Osborne, PhD, Rodney Smith, MD, Francesco Zaja, MD

Blood (2013) 122 (21): 3052.

https://doi.org/10.1182/blood.V122.21.3052.3052

Published: 2013

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Grzegorz W. Basak, MD, PhD, Wieslaw W. Jedrzejczak, MD, PhD, Helene Schoemans, MD, Per T. Ljungman, MD, PhD, Guido Kobbe, MD, Yves Beguin, MD, PhD, Peter Lang, MD, Karl-Walter Sykora, MD, Liane CJ te Boome, MD, Anja van Biezen, Steffie van der Werf, Mohamad Mohty, MD, PhD, Theo de Witte, MD, Judith Marsh, Peter Dreger, MD, Nicolaus Kroeger, MD, Rafael F. Duarte, MD, PhD, Tapani Ruutu, MD PhD

Blood (2013) 122 (21): 2110.

https://doi.org/10.1182/blood.V122.21.2110.2110

Published: 2013

Journal Articles

Activation of the NLRP1 Inflammasome Induces the Pyroptotic Death of Hematopoietic Progenitor Cells

Seth L. Masters, Mordechay Gerlic, Donald Metcalf, Simon P. Preston, Marc Pellegrini, Joanne A. O'Donnell, Kate McArthur, Tracey M. Baldwin, Stephane Chevrier, Cameron J. Nowell, Louise H. Cengia, Katya J. Henley, Janelle E. Collinge, Daniel L. Kastner, Lionel Feigenbaum, Douglas J. Hilton, Warren S. Alexander, Ben A. Croker, Benjamin T. Kile

Blood (2012) 120 (21): 1213.

https://doi.org/10.1182/blood.V120.21.1213.1213

Published: 2012

NARROW

Myocarditis, kidney injury, and hypereosinophilia: FIP1L1-PDGFRA -positive myeloid/lymphoid neoplasm with eosinophilia

Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience

Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML

Pattern of Immune-Mediated Toxicities in Patients with Myelodysplastic Syndrome (MDS) Treated with Nivolumab and Ipilimumab

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Frequency of Anti-PF4/Heparin Antibodies in Patients Treated with Extra-Corporeal Membrane Oxygenation and Detection By Sensitized Serotonin Release Assay of Pathogenic Heparin-Induced Thrombocytopenia Antibodies

Splenectomy Is a Risk Factor for Cardiac Complications in TM

Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab and Bendamustine in Patients with Previously Untreated Follicular Lymphoma: An Interim Analysis

Optimizing Checkpoint Blockade As a Treatment for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Carfilzomib in Combination with Bendamustine and Dexamethasone (CBd) in Relapsed and/or Refractory Patients with Multiple Myeloma: The Phase I/II EMN09 Study

Preliminary Results from a Phase 1/2 Study of DSP-7888, a Novel WT1 Peptide-Based Vaccine, in Patients with Myelodysplastic Syndrome (MDS)

Role of the Thrombin-PAR-1 Pathway in Coxsackievirus Induced Hepatitis

Assessment of Incidence Toxoplasma Gondii Infection and Outcomes in Allogeneic Stem Cell Patients

Dysregulated Overexpression of S100A8 and S100A9 Calgranulin Family Proteins in IFNγR-/- Allogeneic T Cells Is Associated with Reduced Graft Versus Host Disease in Vivo

Multiple roles of the coagulation protease cascade during virus infection

A Randomized Comparison Of Maintenance Therapy With Subcutaneous Rituximab For 2 Years Versus Until Progression In Patients With Indolent Non-Hodgkin’s Lymphoma: Interim Safety Data From The Mabcute Study

Allogeneic Hematopoietic Stem Cell Transplantation Is Feasible After Solid Organ Transplantation: A Retrospective Analysis By The Early Complications Subcommittee Of The Complications and Quality Of Life Working Party, EBMT

Activation of the NLRP1 Inflammasome Induces the Pyroptotic Death of Hematopoietic Progenitor Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only